Top news
All coverage
As some hail new antibody treatment for Alzheimer's, safety and benefit questions persist
By Charles Piller & Jennifer Couzin
Alzheimer's drug from Eisai and Biogen slows cognitive decline, side-effects in focus
By Deena Beasley
New data shows Alzheimer's drug can slow cognitive decline
By Sony Salzman & Mary Kekatos
Alzheimer's drug lecanemab may slow losses in memory and thinking, study says : Shots - Health News
By Jon Hamilton
Alzheimer's drug slows decline in patients
By Eleanor Hayward
Alzheimer's drug lecanemab hailed as momentous breakthrough
By James Gallagher
Experimental drug appears to slow progression of Alzheimer's disease in clinical trial but raises safety concerns
By Jacqueline Howard
Focus: Rare success for Alzheimer's research unlocks hope for future therapies
By Julie Steenhuysen